A phase I pharmacokinetic and pharmacodynamic study of AT7519, a cyclin-dependent kinase inhibitor in patients with refractory solid tumors (Q37843139)
Jump to navigation
Jump to search
scientific article published on 16 February 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase I pharmacokinetic and pharmacodynamic study of AT7519, a cyclin-dependent kinase inhibitor in patients with refractory solid tumors |
scientific article published on 16 February 2011 |
Statements
1 reference
A phase I pharmacokinetic and pharmacodynamic study of AT7519, a cyclin-dependent kinase inhibitor in patients with refractory solid tumors (English)
1 reference
D Mahadevan
1 reference
R Plummer
1 reference
M S Squires
1 reference
D Rensvold
1 reference
S Kurtin
1 reference
C Pretzinger
1 reference
T Dragovich
1 reference
J Adams
1 reference
V Lock
1 reference
D M Smith
1 reference
D Von Hoff
1 reference
H Calvert
1 reference
16 February 2011
1 reference
1 reference
22
1 reference
9
1 reference
2137-2143
1 reference
Identifiers
1 reference
1 reference